Skip to main content
Fig. 6 | Stem Cell Research & Therapy

Fig. 6

From: Combination therapy of menstrual derived mesenchymal stem cells and antibiotics ameliorates survival in sepsis

Fig. 6

Septic mice show higher retention of the injected MenSCs in the peritoneal cavity in comparison with healthy control mice. MenSCs were labelled with PKH-26 and analyzed by flow cytometry. a Fluorescence-activated cell sorting plot showing a 95 % labelling efficiency. Around 2 × 106 cells were injected intraperitoneally in septic or healthy mice. b Histogram and representative flow cytometry plots showing the percentage of remaining cells in peritoneal lavage at 24 hours post-injection. CLP cecal ligation puncture, MenSCs menstrual derived mesenchymal stem cells

Back to article page